Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | MMP9 | P14780 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 8/20 | 0.45 |
| ▸ | CA9 | Q16790 | 7/20 | 0.45 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 7/20 | 0.32 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1606138 | 0.93 | TSHR (0.65) | ALDH1A1TSHRLMNAUSP2KDM4E | |
| SCHEMBL8723938 | 0.91 | TSHR (0.62) | ALDH1A1TSHRLMNAUSP2KDM4E | |
| SCHEMBL9432188 | 0.91 | TSHR (0.62) | ALDH1A1TSHRLMNAUSP2KDM4E | |
| SCHEMBL20495987 | 0.91 | TSHR (0.62) | ALDH1A1TSHRLMNAUSP2KDM4E | |
| SCHEMBL11176516 | 0.91 | TSHR (0.62) | ALDH1A1TSHRLMNAUSP2KDM4E | |
| SCHEMBL1606611 | 0.91 | TSHR (0.62) | ALDH1A1TSHRLMNAUSP2KDM4E | |
| SCHEMBL11250193 | 0.90 | LMNA (0.50) | ALDH1A1TSHRLMNAUSP2KDM4E | |
| SCHEMBL11250191 | 0.90 | LMNA (0.50) | ALDH1A1TSHRLMNAUSP2KDM4E | |
| SCHEMBL6523465 | 0.88 | ALDH1A1 (0.46) | ALDH1A1TSHRLMNAUSP2KDM4E | |
| SCHEMBL10593617 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116940581-A | Novel protein degradation agent and application thereof | 和径医药科技（上海）有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-109148953-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same | 三菱化学株式会社 | 2019-01-04 | — | — | CN | disclosed |
| EP-2913331-B1 | METHOD FOR PRODUCING EPOXY COMPOUND | NISSAN CHEMICAL IND LTD (JP) | 2018-09-12 | — | — | EP | disclosed |
| CN-104797576-B | The manufacture method of epoxide | 日产化学工业株式会社 | 2018-05-01 | — | — | CN | disclosed |
| US-9464074-B2 | Method for producing epoxy compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-10-11 | — | — | US | disclosed |
| US-20150284372-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-10-08 | — | — | US | disclosed |
| EP-2913331-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2015-09-02 | — | — | EP | disclosed |
| CN-104797576-A | Method for producing epoxy compound | NISSAN CHEMICAL IND LTD | 2015-07-22 | — | — | CN | disclosed |
| US-9023583-B2 | Monolayer or multilayer forming composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-05-05 | — | — | US | disclosed |
| CN-103339784-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same | MITSUBISHI CHEM CORP | 2013-10-02 | — | — | CN | disclosed |
| US-20130216956-A1 | MONOLAYER OR MULTILAYER FORMING COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-08-22 | — | — | US | disclosed |
| EP-0983248-B1 | ANALOGS OF DUOCARMYCIN AND CC-1065 | SCRIPPS RESEARCH INST (US) | 2004-07-14 | — | — | EP | disclosed |
| US-6281354-B1 | ANTIBIOTICS; ANTITUMOR AGENTS | THE SCRIPPS RESEARCH INSTITUTE | 2001-08-28 | — | — | US | disclosed |
| EP-0983248-A4 | ANALOGS OF DUOCARMYCIN AND CC-1065 | SCRIPPS RESEARCH INST (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-0983248-A1 | ANALOGS OF DUOCARMYCIN AND CC-1065 | The Scripps Research Institute (US) | 2000-03-08 | — | — | EP | disclosed |
| WO-1998052925-A1 | ANALOGS OF DUOCARMYCIN AND CC-1065 | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150284372-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | NOX5, NOX4, NOXO1 | ALDH1A1 1087/4885TSHR 2308/4885LMNA 4076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.